Medscape Medical Affairs

Partnering with medical affairs teams through a product’s life cycle to facilitate collaboration & connection with our 6.5 million physician members worldwide.

[Medscape Medical Affairs @MedscapeMedAff]

Kicking off #TREX26 with a can't-miss Keynote: Targeting the RAS Oncogene in Cancer + insights on drug repurposing & reformulation.

Join: @GustaveRoussy @DanaFarber
🔗 https://t.co/MdigzNkdiC

[Medscape Medical Affairs @MedscapeMedAff]

🧬 Discover expert insights on Targeting the RAS Oncogene in Cancer at the #TREX26 Keynote. A critical discussion on a historically difficult therapeutic target.

👨‍⚕️ Experts: @DrChoueiri @AlbigesL @KevinHaigisLab
🔗 https://t.co/MdigzNkdiC

[Medscape Medical Affairs @MedscapeMedAff]

Collaboration is key to innovation!
Join us to learn about Epigenetics and a special Fellowship Exchange Program research from DFCI & IGR.
🗓️ 01:00 PM - 04:45 PM ET
Register now and secure your seat: https://t.co/MdigzNkL8a
@DanaFarber + @GustaveRoussy

[Medscape Medical Affairs @MedscapeMedAff]

The future of cancer care is here! Don't miss the keynote on "Targeting the RAS Oncogene" followed by discussions on Cell Therapies Beyond T Cells & the Role of the Microbiome in Immunity.

Register here now: https://t.co/MdigzNkdiC

Joins: @DrChoueiri, @AlbigesL, @KevinHaigisLab

[Medscape Medical Affairs @MedscapeMedAff]

Don’t miss the Keynote Address at the 5th Transatlantic Exchange in Oncology #TREX26

This featured session will focus on a critical and complex area of cancer research: Targeting the RAS Oncogene in Cancer

🔗 https://t.co/MdigzNkL8a

Join:@GustaveRoussy @DanaFarberNews @Servier

[Medscape Medical Affairs @MedscapeMedAff]

Why Attend-5th Transatlantic Exchange in Oncology?
Kicking off the #TREX26 with a deep dive into Drug Repurposing and Reformulation! Learn how experts are finding new applications for existing therapies. 🗓️ 09:10 - 10:10 AM ET– Register here now: https://t.co/MdigzNkdiC

[Medscape Medical Affairs @MedscapeMedAff]

📌 NCFBE: a chronic, progressive respiratory disease that is often underrecognized.
📈 Improve disease recognition, pathogenesis insights, and future therapy knowledge in this live webinar .
👉 Register: https://t.co/cgIfrsyFqC

[Medscape Medical Affairs @MedscapeMedAff]

💡 Chronic cough isn’t always asthma or COPD… could it be NCFBE? 👨‍⚕️ Learn diagnostic clues + the latest therapies in our live webinar w/ leading experts.✨ Join here: https://t.co/cgIfrsyFqC

[Medscape Medical Affairs @MedscapeMedAff]

🫁 Misdiagnosis in NCFBE is common—NCFBE is often mistaken for asthma or COPD.
📊 Join experts to review diagnostic criteria, pathogenesis & future therapies targeting airway inflammation and infection.
👉 Don’t miss it: https://t.co/cgIfrsy7B4

[Medscape Medical Affairs @MedscapeMedAff]

🚨 Bronchiectasis: more than just airway disease. Dive into NCFBE pathophysiology, diagnostic pitfalls & emerging therapies in this must-watch webinar! 🔗Join us by clicking here: https://t.co/TTT6E8Hv1u #Bronchiectasis

[Medscape Medical Affairs @MedscapeMedAff]

🎥 Think it's asthma or COPD? Think again. 🫁 Join us to explore pathophysiology, diagnostic challenges and emerging therapies in non-cystic fibrosis bronchiectasis. Don’t miss the live Q&A! 🔗 Register Now: https://t.co/5kb6xaMSTW #NCFBE

[Medscape Medical Affairs @MedscapeMedAff]

📣 The 2025 Transatlantic Exchange in Oncology focuses on "Radiopharmaceutical Therapy Meets Oncology"! Don’t miss insights from top experts. 📆 March 19 in Paris or online. Register now: https://t.co/8aMRux1ACA
@DrChoueiri @barlesi @HJacene @KevinHaigisLab @FAndreMD

[Medscape Medical Affairs @MedscapeMedAff]

💡 Radiopharmaceutical therapy is reshaping oncology! Be part of the conversation at the 2025 Transatlantic Exchange in Oncology—March 19 in Paris or online. 🌍 Learn more & register: https://t.co/svjyH2lIqh

@DrChoueiri @barlesi @HJacene @KevinHaigisLab @FAndreMD

[Medscape Medical Affairs @MedscapeMedAff]

🚨 Don’t miss the 2025 Transatlantic Exchange in Oncology! 🌍 Join us in Paris or online on March 19, as world-leading experts discuss innovations in radiopharmaceutical therapy. 💡 Register now: https://t.co/UYk6hf5aKv
@DrChoueiri @barlesi @HJacene @KevinHaigisLab @FAndreMD

[Medscape Medical Affairs @MedscapeMedAff]

🔬 Dive into hereditary angioedema (HAE) with our Journal Club! Explore unmet needs, review some of the novel treatments in Phase 3 trial investigation for HAE, and join the Q&A 🗯️ . Click here to register: https://t.co/mBibBnmtVu

[Medscape Medical Affairs @MedscapeMedAff]

🚨 Join our Journal Club to uncover the challenges of hereditary angioedema (HAE). Review key insights from some of the novel treatments in Phase 3 trial investigation for HAE and get your questions answered. Click here to register: https://t.co/y2paYnGCvp

[Medscape Medical Affairs @MedscapeMedAff]

🔍 Get the latest on hereditary angioedema (HAE) at our Journal Club! Discuss and review some of the novel treatments in Phase 3 trial investigation for HAE and its impact on HAE management. Catch this event here: https://t.co/NT78RMfysu

[Medscape Medical Affairs @MedscapeMedAff]

Last chance to register! Join us in Bangkok at #ISTH2024 on 23 June for this BMS-Pfizer Satellite Symposium and learn, through different VTE cases, where we are now regarding NOACs use for VTE treatment and prevention of VTE recurrence. Reserve your spot https://t.co/5Nvv7HSKs6

[Medscape Medical Affairs @MedscapeMedAff]

Register for #ISTH2024 Symposium - Your Frequently Asked Questions: Our Responses on VTE Anticoagulation. Join Drs @AnderCohen, Jenny Curnow, Chatree Chai-Adisaksopha, and Bundarika Suwanawiboon on 23 June 12:15 – 13:30 ICT in Bangkok. Reserve your spot https://t.co/5Nvv7HSKs6

[Medscape Medical Affairs @MedscapeMedAff]

2 weeks away! Register for our upcoming #ISTH2024 symposium in Bangkok on 23 June: Your Frequently Asked Questions: Our Responses on VTE Anticoagulation and follow a case-based discussion on NOACs use for VTE treatment and prevention of VTE recurrence https://t.co/5Nvv7HSKs6